Celyad SA risk profile

64 Stretched several inputs deteriorating together

Measured 1 September 2026 from CYAD's filed statements. Recomputed nightly.

64 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation78StretchedStableDrawdown from the 52-week high — 47.3%
Operating pressure65StretchedWorseningCosts outgrowing revenue — +11.3 percentage points
Cash conversion100AcuteStableCash conversion — -8.31x
Leverage and coverage10ContainedEasingCurrent ratio — 1.92x
Competitive position69StretchedStableOperating-margin gap against peers — -6,201.5 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Celyad SA